225 related articles for article (PubMed ID: 33430962)
1. MicroRNA-320a: an important regulator in the fibrotic process in interstitial lung disease of systemic sclerosis.
Li Y; Huang J; Hu C; Zhou J; Xu D; Hou Y; Wu C; Zhao J; Li M; Zeng X; Liu C; Wang Q; Zhao Y
Arthritis Res Ther; 2021 Jan; 23(1):21. PubMed ID: 33430962
[TBL] [Abstract][Full Text] [Related]
2. miR-155 in the progression of lung fibrosis in systemic sclerosis.
Christmann RB; Wooten A; Sampaio-Barros P; Borges CL; Carvalho CR; Kairalla RA; Feghali-Bostwick C; Ziemek J; Mei Y; Goummih S; Tan J; Alvarez D; Kass DJ; Rojas M; de Mattos TL; Parra E; Stifano G; Capelozzi VL; Simms RW; Lafyatis R
Arthritis Res Ther; 2016 Jul; 18(1):155. PubMed ID: 27377409
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-29, a key regulator of collagen expression in systemic sclerosis.
Maurer B; Stanczyk J; Jüngel A; Akhmetshina A; Trenkmann M; Brock M; Kowal-Bielecka O; Gay RE; Michel BA; Distler JH; Gay S; Distler O
Arthritis Rheum; 2010 Jun; 62(6):1733-43. PubMed ID: 20201077
[TBL] [Abstract][Full Text] [Related]
4. TGF-β-mediated downregulation of microRNA-196a contributes to the constitutive upregulated type I collagen expression in scleroderma dermal fibroblasts.
Honda N; Jinnin M; Kajihara I; Makino T; Makino K; Masuguchi S; Fukushima S; Okamoto Y; Hasegawa M; Fujimoto M; Ihn H
J Immunol; 2012 Apr; 188(7):3323-31. PubMed ID: 22379029
[TBL] [Abstract][Full Text] [Related]
5.
He Y; Liu H; Wang S; Chen Y
DNA Cell Biol; 2019 Sep; 38(9):933-944. PubMed ID: 31361540
[TBL] [Abstract][Full Text] [Related]
6. Integrative analysis of lung molecular signatures reveals key drivers of systemic sclerosis-associated interstitial lung disease.
Jung SM; Park KS; Kim KJ
Ann Rheum Dis; 2022 Jan; 81(1):108-116. PubMed ID: 34380701
[TBL] [Abstract][Full Text] [Related]
7. Interstitial Lung Disease in Patients With Systemic Sclerosis: Toward Personalized-Medicine-Based Prediction and Drug Screening Models of Systemic Sclerosis-Related Interstitial Lung Disease (SSc-ILD).
Khedoe P; Marges E; Hiemstra P; Ninaber M; Geelhoed M
Front Immunol; 2020; 11():1990. PubMed ID: 33013852
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-130b regulates scleroderma fibrosis by targeting peroxisome proliferator-activated receptor γ.
Luo H; Zhu H; Zhou B; Xiao X; Zuo X
Mod Rheumatol; 2015 Jul; 25(4):595-602. PubMed ID: 25547017
[TBL] [Abstract][Full Text] [Related]
9. Netrin-1 Regulates Fibrocyte Accumulation in the Decellularized Fibrotic Sclerodermatous Lung Microenvironment and in Bleomycin-Induced Pulmonary Fibrosis.
Sun H; Zhu Y; Pan H; Chen X; Balestrini JL; Lam TT; Kanyo JE; Eichmann A; Gulati M; Fares WH; Bai H; Feghali-Bostwick CA; Gan Y; Peng X; Moore MW; White ES; Sava P; Gonzalez AL; Cheng Y; Niklason LE; Herzog EL
Arthritis Rheumatol; 2016 May; 68(5):1251-61. PubMed ID: 26749424
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-21 and microRNA-29a modulate the expression of collagen in dermal fibroblasts of patients with systemic sclerosis.
Jafarinejad-Farsangi S; Gharibdoost F; Farazmand A; Kavosi H; Jamshidi A; Karimizadeh E; Noorbakhsh F; Mahmoudi M
Autoimmunity; 2019 May; 52(3):108-116. PubMed ID: 31155965
[TBL] [Abstract][Full Text] [Related]
11. [Expression and clinical significance of plasma exosomal miR-34-5p and miR-142-3p in systemic sclerosis].
Li WG; Gu XD; Weng RQ; Liu SD; Chen C
Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Dec; 55(6):1022-1027. PubMed ID: 38101783
[TBL] [Abstract][Full Text] [Related]
12. MiR-3606-3p inhibits systemic sclerosis through targeting TGF-β type II receptor.
Shi X; Liu Q; Li N; Tu W; Luo R; Mei X; Ma Y; Xu W; Chu H; Jiang S; Du Z; Zhao H; Zhao L; Jin L; Wu W; Wang J
Cell Cycle; 2018; 17(16):1967-1978. PubMed ID: 30145936
[TBL] [Abstract][Full Text] [Related]
13. Downregulation of miR-542-3p Contributes to Apoptosis Resistance in Dermal Fibroblasts from Systemic Sclerosis Patients via Survivin Overexpression.
Vahidi Manesh P; Farazmand A; Gharibdoost F; Vanaki N; Mostafaei S; Kavosi H; Mahmoudi MB; Mahmoudi M
Iran J Allergy Asthma Immunol; 2019 Apr; 18(2):173-181. PubMed ID: 31066253
[TBL] [Abstract][Full Text] [Related]
14. Single-cell analysis reveals fibroblast heterogeneity and myofibroblasts in systemic sclerosis-associated interstitial lung disease.
Valenzi E; Bulik M; Tabib T; Morse C; Sembrat J; Trejo Bittar H; Rojas M; Lafyatis R
Ann Rheum Dis; 2019 Oct; 78(10):1379-1387. PubMed ID: 31405848
[TBL] [Abstract][Full Text] [Related]
15. CXCL17-mediated downregulation of type I collagen via MMP1 and miR-29 in skin fibroblasts possibly contributes to the fibrosis in systemic sclerosis.
Shimada S; Makino K; Jinnin M; Sawamura S; Kawano Y; Ide M; Kajihara I; Makino T; Fukushima S; Ihn H
J Dermatol Sci; 2020 Dec; 100(3):183-191. PubMed ID: 33055012
[TBL] [Abstract][Full Text] [Related]
16. Nintedanib downregulates the profibrotic M2 phenotype in cultured monocyte-derived macrophages obtained from systemic sclerosis patients affected by interstitial lung disease.
Soldano S; Smith V; Montagna P; Gotelli E; Campitiello R; Pizzorni C; Paolino S; Sulli A; Cere A; Cutolo M
Arthritis Res Ther; 2024 Mar; 26(1):74. PubMed ID: 38509595
[TBL] [Abstract][Full Text] [Related]
17. Alteration of circulating miRNAs in SSc: miR-30b regulates the expression of PDGF receptor β.
Tanaka S; Suto A; Ikeda K; Sanayama Y; Nakagomi D; Iwamoto T; Suzuki K; Kambe N; Matsue H; Matsumura R; Kashiwakuma D; Iwamoto I; Nakajima H
Rheumatology (Oxford); 2013 Nov; 52(11):1963-72. PubMed ID: 23893664
[TBL] [Abstract][Full Text] [Related]
18. Critical Role of LMCD1 in Promoting Profibrotic Characteristics of Lung Myofibroblasts in Experimental and Scleroderma-Associated Lung Fibrosis.
Bogatkevich GS; Atanelishvili I; Bogatkevich AM; Silver RM
Arthritis Rheumatol; 2023 Mar; 75(3):438-448. PubMed ID: 36103378
[TBL] [Abstract][Full Text] [Related]
19. High serum C-X-C motif chemokine ligand 10 (CXCL10) levels may be associated with new onset interstitial lung disease in patients with systemic sclerosis: evidence from observational, clinical, transcriptomic and in vitro studies.
Al-Adwi Y; Atzeni IM; Doornbos-van der Meer B; van der Leij MJ; Varkevisser RDM; Kroesen BJ; Stel A; Timens W; Gan CT; van Goor H; Westra J; Mulder DJ
EBioMedicine; 2023 Dec; 98():104883. PubMed ID: 37995465
[TBL] [Abstract][Full Text] [Related]
20. Crosstalk between the JAK2 and TGF-β1 signaling pathways in scleroderma-related interstitial lung disease targeted by baricitinib.
Wang D; Wei Y; Xu L; Zhang J
Adv Rheumatol; 2023 May; 63(1):22. PubMed ID: 37194022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
